MDCG 2023-3 Rev 1 released
MDCG 2023-3 Rev 1 released
Friday, 15 November 2024
Kirsten Van Garsse, Authorized Representative Director & Regulatory Affairs Manager IVD
Share
\
\
X (Twitter)
\
\
LinkedIn
\
\
WhatsApp
\
\
Copy link
\
\
Mail
On November 11th, 2024, the Medical Device Coordination Group (MDCG) released its first revision (MDCG 2023-3 Rev 1) of the questions and Answers on vigilance terms and concepts as outlined in the Regulation (EU) 2017/745 and Regulation (EU) 2017/746. MDCG 2023-3 provides a clearer framework for key terms and concepts essential to implementing the vigilance requirements under EU Regulations (MDR 2017/745 and IVDR 2017/746). Aimed at competent authorities, economic operators, and other stakeholders, the document harmonizes definitions for effective regulatory compliance.
Some key takeaways from the revised MDCG
The updated MDCG 2023-3 guidance expands its scope to include the IVDR, alongside general clarifications to support stakeholders in implementing vigilance requirements.
Some key updates include:
- Enhanced Definitions: A new table clearly distinguishes ‘incident’ and ‘serious incident’ under both the MDR and IVDR.
- Flowchart Update: The decision-making flowchart has been revised to explicitly reference both regulations.
- Targeted Examples: Examples specific to IVDR have been added, alongside new cases applicable to both MDR and IVDR.
- Additional Questions: New questions have been included to address practical considerations across both regulatory frameworks.
These updates aim to ensure consistent interpretation and effective application of vigilance requirements under the MDR and IVDR.
What does it mean to you?
This new revision is key for Medical Device and IVD manufacturers to ensure your vigilance procedures are aligned with the updated definitions and examples. In addition the revision is useful for economic operators and other stakeholders to familiarize themselves with the updated guidance to remain compliant, especially when reporting incidents or conducting post-market surveillance.
Discover more expert content
Previous
Regulatory Affairs
27 May 2024
New MDCG & Stakeholders Survey on MDR/IVDR Certifications and Applications Released by Notified Bodies
On May 17th, 2024, the European Commission released the survey results of the 8th Notified Body...
Regulatory Affairs
17 Dec 2025
MHRA publishes new IVD Roadmap
The roadmap sets out broad timelines and planned activities across three key themes:
Regulatory Affairs
6 Nov 2024
MDCG 2024-13 and MDCG 2022-5 Rev 1 released
On October 29th, 2024, the Medical Device Coordination Group (MDCG) released a new guidance (MDCG...
Regulatory Affairs
22 Apr 2024
New MDCG Guidance on Safety Reporting for Performance Studies of In Vitro Diagnostic Medical Devices under EU Regulation 2017/746 Released
On April 15th, 2024, the Medical Device Coordination Group (MDCG) released a new guidance document...
Regulatory Affairs
15 Mar 2024
New MDCG Guidance Released: Detailed Instructions for Clinical Investigation Plans in Medical Device Studies
New MDCG Guidance documents released: Guidance on the content of the Clinical Investigation Plan...
Regulatory Affairs
27 May 2024
New MDCG & Stakeholders Survey on MDR/IVDR Certifications and Applications Released by Notified Bodies
On May 17th, 2024, the European Commission released the survey results of the 8th Notified Body...
Regulatory Affairs
17 Dec 2025
MHRA publishes new IVD Roadmap
The roadmap sets out broad timelines and planned activities across three key themes:
Regulatory Affairs
6 Nov 2024
MDCG 2024-13 and MDCG 2022-5 Rev 1 released
On October 29th, 2024, the Medical Device Coordination Group (MDCG) released a new guidance (MDCG...
Regulatory Affairs
22 Apr 2024
New MDCG Guidance on Safety Reporting for Performance Studies of In Vitro Diagnostic Medical Devices under EU Regulation 2017/746 Released
On April 15th, 2024, the Medical Device Coordination Group (MDCG) released a new guidance document...
Regulatory Affairs
15 Mar 2024
New MDCG Guidance Released: Detailed Instructions for Clinical Investigation Plans in Medical Device Studies
New MDCG Guidance documents released: Guidance on the content of the Clinical Investigation Plan...
Regulatory Affairs
27 May 2024
New MDCG & Stakeholders Survey on MDR/IVDR Certifications and Applications Released by Notified Bodies
On May 17th, 2024, the European Commission released the survey results of the 8th Notified Body...
Regulatory Affairs
17 Dec 2025
MHRA publishes new IVD Roadmap
The roadmap sets out broad timelines and planned activities across three key themes:
Next
- 1
- 2
- 3
Stay ahead in life sciences
Keeping up with the fast-paced life sciences industry doesn’t have to be overwhelming.
Our newsletter delivers the latest insights, industry updates, and expert content directly to your inbox, helping you stay informed and make smarter decisions.
Twitter Widget Iframe

